Rapid investigating of phase I metabolites of SR9009 in vitro horse liver microsomes via feature-based molecular networking approach: Potential applications in …

YB Kwak, J Yoon, HH Yoo - Journal of Pharmaceutical and Biomedical …, 2024 - Elsevier
SR9009, a peroxisome proliferator-activated receptor δ (PPARδ) agonist, is known for its
potential benefits in energy homeostasis. It failed to receive the United States Food and …